ロード中...

Stable Dry Powder Formulation for Nasal Delivery of Anthrax Vaccine

There is a current biodefense interest in protection against Anthrax. Here we developed a new generation of stable and effective anthrax vaccine. We studied the immune response elicited by rPA delivered intranasally with a novel mucosal adjuvant, a mast cell activator Compound 48/80. The vaccine for...

詳細記述

保存先:
書誌詳細
主要な著者: Wang, Sheena H., Kirwan, Shaun M., Abraham, Soman N., Staats, Herman F., Hickey, Anthony J.
フォーマット: Artigo
言語:Inglês
出版事項: 2011
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3725471/
https://ncbi.nlm.nih.gov/pubmed/21905034
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jps.22742
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!